Case report
A woman aged 28 attended the department of genitourinary medicine in October 1984. She had been referred by her general practitioner who, for the previous three years, had been treating her unsuccessfully for a recurrent offensive vaginal discharge (details of the drug regimen prescribed are not available). At her first visit to the clinic, Trichomonas vaginalis was found in a wet preparation of vaginal secretions, and metronidazole 200 mg three times a day for one week was prescribed.
During the next six months she had recurrent symptomatic trichomoniasis, which was found to coincide with menstruation. Varying treatment regimens were used, including oral metronidazole ranging from 600 mg to 12 g a day, nimorazole 2 g as a single oral dose, and metronidazole 1 g suppositories used daily as pessaries. On three occasions erythromycin, doxycycline, or septrin was given concurrently, as it has been suggested that concomitant bacteria may inactivate metronidazole. 3 These agents were used because the patient stated that she was allergic to penicillin. In addition, acidifying preparations, such as acetic acid vaginal jelly and povidone-iodine pessaries, were used during menstruation. She had had only one sexual partner during the previous eight years, and he was also given concurrent epidemiological treatment on three separate occasions. Sexual activities were stated to have been discontinued for at least a month during medication.
As the infection persisted, further investigations were carried out. A full gynaecological examination showed no abnormality. High vaginal secretions were cultured for the presence of organisms that possibly inactivate metronidazole (Escherichia coli, Streptococcus milleri, and Bacteroidesfragilis were isolated). Serum zinc concentrations were measured and found to be within normal limits at 14-0 Mmol/1.45 Using the method described by Nielsen,6 the minimum inhibitory concentrations (MICs) of metronidazole for T vaginalis isolated on two occasions two months apart were examined and found to be 2 mg/I under aerobic conditions (table 1). As the organism was not resistant to metronidazole, investigations were undertaken to exclude inadequate absorption of this agent. Serum and vaginal concentrations one hour after the patient had received 800 mg by mouth were assayed microbiologically by a plate diffusion method,7 and were found to be satisfactory (table 2) . 369 24 led us to assay serum zinc concentrations in our patient, but they were found to be within normal limits.
Abnormalities of hosts may account for failure to respond to treatment. Immunological studies of our patient showed no evidence of a generalised immunodeficiency state or of T cell immune deficiency against the trichomonal isolate. In view ofthe normal immune response, we decided to undertake immunisation with a lyophilisate of inactivated selected strains of L acidophilus. The mode of action is not certain, but the vaccine may induce cross reacting antibodies against T vaginalis and abnormal lactobacilli without adversely affecting the growth of normal lactobacilli in the vagina. Lorenz and Ruttgers reported that after the third vaccination no trichomonads could be found in 84% ofwomen, and after one year this figure had risen to 96%.25 Reinfection after completion of the course and a booster vaccination occurred in only 4-5% of cases. Unfortunately the vaccine did not prove successful in our patient; T vaginalis was seen in wet preparations during the vaccination schedule and four and nine weeks afterwards. Forsgren and Forssman speculated that suboptimal doses of metronidazole in vaginal secretions may induce resistance to imidazole. '7 The difference in sensitivity of isolates could be attributed to reinfection. Our patient appeared to be reliable and said that she had had only one regular sexual partner for many years, and her consort said that he had had no other sexual contacts. Although it is unlikely, however, another sexual partner cannot be categorically discounted.
In this patient, symptomatic trichomoniasis invariably started at the onset of menstruation, and she remained asymptomatic throughout her pregnancy. The pH of the vagina decreases from a mean of 6.6 in week one of the menstrual cycle to 4.3 in week four,29 and in pregnancy varies from 3.8-4.4.? This acid environment may prove unsuitable for T vaginalis, as the organism appears to prefer a pH of 5-8.`' After the satisfactory completion of her pregnancy the patient was again found to harbour T vaginalis (with an MIC of64 mg/I). This could be attributed to reinfection, but T vaginalis may have persisted in some other genitourinary or gastrointestinal site and been able to re-establish infection when the vaginal pH returned to normal after parturition.
In this report we present the history ofa patient with recalcitrant trichomoniasis that failed to respond to all forms of treatment. There is clearly a need for alternative antitrichomonal treatment. Sears and O'Hare assessed the susceptibility of a metronidazole resistant strain of T vaginalis to a range of antimicrobial agents, and found that mebendazole, furazolidone, and anisonmycin were the most active.32 Whether these in vitro findings offer an alternative successful approach in the clinical situation needs further study.
